TNF and toxic epidermal necrolysis: The literature has seen a growing body of case reports that report benefit from anti-TNF-α treatment in TEN following the use of infliximab,1,8–11 adalimumab12 and more recently, etanercept,13–34 with cessation of epidermal detachment and subsequent re-epithelialization of the skin.